Recent Price Movement and Market Context
On 6 March 2026, Jaysynth Orgochem Ltd’s stock price fell by 1.91%, closing at Rs.11.26, the lowest level in the past year. This decline outpaced the sector’s underperformance, with the stock lagging the specialty chemicals sector by 2.58% on the day. The broader market also faced pressure, with the Sensex opening 356.91 points lower and trading at 79,636.00, down 0.47%. Notably, the Sensex is trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating some underlying market resilience.
Jaysynth Orgochem’s share price has been trending below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. The stock’s 52-week high was Rs.24.70, highlighting a steep decline of approximately 54.4% from that peak.
Financial Performance and Profitability Trends
The company’s recent quarterly results have contributed to the subdued market sentiment. For the quarter ending December 2025, Jaysynth Orgochem reported a Profit Before Tax (PBT) of Rs.2.78 crore, which represents a decline of 36.9% compared to the average of the previous four quarters. Similarly, the Profit After Tax (PAT) stood at Rs.2.33 crore, down 38.6% relative to the prior four-quarter average. Operating profit to net sales ratio also reached a low of 5.96% in the quarter, reflecting margin pressures.
Over the past year, the company’s profits have decreased by 16.7%, a factor that has weighed on investor confidence. This contrasts with the broader BSE500 index, which has delivered a positive return of 10.37% over the same period. Jaysynth Orgochem’s one-year stock performance has been notably weaker, with a decline of 46.89%, compared to the Sensex’s gain of 7.18%.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Valuation and Financial Health Metrics
Despite recent setbacks, Jaysynth Orgochem maintains certain financial strengths. The company exhibits a low Debt to EBITDA ratio of 0.80 times, indicating a strong capacity to service its debt obligations. This conservative leverage profile is a positive aspect amid the current price weakness.
Long-term growth metrics also show promise, with net sales growing at an annualised rate of 199.36% and operating profit increasing by 72.54% annually. Return on Capital Employed (ROCE) stands at 13.3%, which is considered attractive within the specialty chemicals sector. Additionally, the company’s enterprise value to capital employed ratio is 1.2, suggesting a valuation discount relative to its peers’ historical averages.
Shareholding and Market Position
The majority shareholding remains with the promoters, providing a stable ownership structure. Jaysynth Orgochem operates within the specialty chemicals industry, a sector that has experienced mixed performance in recent months. The company’s market capitalisation grade is rated 4, reflecting its mid-tier market size within the sector.
Comparative Performance and Market Sentiment
Jaysynth Orgochem’s Mojo Score currently stands at 31.0, with a Mojo Grade of Sell, downgraded from Hold on 5 August 2025. This downgrade reflects the deteriorating financial metrics and price performance. The stock’s underperformance relative to both the Sensex and the BSE500 index over the past year underscores the challenges faced by the company in maintaining investor confidence.
Holding Jaysynth Orgochem Ltd from Specialty Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Metrics
To summarise, Jaysynth Orgochem Ltd’s stock has declined to Rs.11.26, its lowest level in 52 weeks, reflecting a combination of weaker quarterly earnings, margin compression, and sustained underperformance relative to market benchmarks. The company’s financial health remains supported by manageable debt levels and strong long-term sales growth, but recent profit declines and valuation pressures have contributed to the current market sentiment.
While the stock trades at a discount compared to peers, the recent downgrade in Mojo Grade to Sell and the ongoing price weakness highlight the challenges faced by Jaysynth Orgochem in the current market environment.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
